CA672478A - Psilocybin and psilocin - Google Patents
Psilocybin and psilocinInfo
- Publication number
- CA672478A CA672478A CA672478A CA672478DA CA672478A CA 672478 A CA672478 A CA 672478A CA 672478 A CA672478 A CA 672478A CA 672478D A CA672478D A CA 672478DA CA 672478 A CA672478 A CA 672478A
- Authority
- CA
- Canada
- Prior art keywords
- psilocin
- psilocybin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA672478T |
Publications (1)
Publication Number | Publication Date |
---|---|
CA672478A true CA672478A (en) | 1963-10-15 |
Family
ID=35972836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA672478A Expired CA672478A (en) | Psilocybin and psilocin |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA672478A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2576059A (en) * | 2017-10-09 | 2020-02-05 | Compass Pathways Ltd | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US11564935B2 (en) | 2019-04-17 | 2023-01-31 | Compass Pathfinder Limited | Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin |
US11724985B2 (en) | 2020-05-19 | 2023-08-15 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
-
0
- CA CA672478A patent/CA672478A/en not_active Expired
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11851451B2 (en) | 2017-10-09 | 2023-12-26 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US10947257B2 (en) | 2017-10-09 | 2021-03-16 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US10954259B1 (en) | 2017-10-09 | 2021-03-23 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US11149044B2 (en) | 2017-10-09 | 2021-10-19 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US11180517B2 (en) | 2017-10-09 | 2021-11-23 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
GB2576059B (en) * | 2017-10-09 | 2022-06-29 | Compass Pathfinder Ltd | A pharmaceutical formulation comprising psilocybin |
US11447510B2 (en) | 2017-10-09 | 2022-09-20 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US11505564B2 (en) | 2017-10-09 | 2022-11-22 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
GB2576059A (en) * | 2017-10-09 | 2020-02-05 | Compass Pathways Ltd | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US11629159B2 (en) | 2017-10-09 | 2023-04-18 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US11939346B2 (en) | 2017-10-09 | 2024-03-26 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
US11564935B2 (en) | 2019-04-17 | 2023-01-31 | Compass Pathfinder Limited | Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin |
US11738035B2 (en) | 2019-04-17 | 2023-08-29 | Compass Pathfinder Limited | Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin |
US11746088B2 (en) | 2020-05-19 | 2023-09-05 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
US11834410B2 (en) | 2020-05-19 | 2023-12-05 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
US11724985B2 (en) | 2020-05-19 | 2023-08-15 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
US11958807B2 (en) | 2020-05-19 | 2024-04-16 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA672478A (en) | Psilocybin and psilocin | |
CA655470A (en) | Muffler | |
AU287361B2 (en) | N-phenyloxyalkyl n-phenalkoxyamines and related compounds | |
CA672962A (en) | Suspended files | |
CA664820A (en) | Oxygenator | |
CA665228A (en) | Acoustic devices | |
AU275537B2 (en) | Acoustic character logging | |
CA673421A (en) | Counterbalance | |
AU289492B2 (en) | Muffler | |
AU289056B2 (en) | Muffler | |
AU291145B2 (en) | Muffler | |
AU288016B2 (en) | Muffler | |
CA670443A (en) | Anti-smog muffler | |
CA656682A (en) | Muffler | |
AU295749B2 (en) | Muffler | |
AU292145B2 (en) | Muffler | |
CA657116A (en) | Muffler | |
AU290765B2 (en) | Muffler | |
AU275017B2 (en) | Muffler | |
AU289482B2 (en) | Muffler | |
AU279499B2 (en) | Iodiphors | |
AU281585B2 (en) | D-homo-steroids | |
AU270797B2 (en) | Anthelmitic 5-arylazorhodanines | |
CA666709A (en) | Disjoncteurs pneumatiques | |
AU269943B2 (en) | 3-aminosteroids |